Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
16.31
-0.57 (-3.41%)
At close: Apr 28, 2026, 4:00 PM EDT
16.40
+0.09 (0.58%)
After-hours: Apr 28, 2026, 4:17 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.80 billion as of April 28, 2026. Its market cap has increased by 483.39% in one year.
Market Cap
1.80B
Enterprise Value
1.48B
1-Year Change
483.39%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.80B, an increase of 68.72%. That is a compound annual growth rate of 12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.87B | 40.65% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.85B |
| Prestige Consumer Healthcare | 2.76B |
| HUTCHMED (China) | 2.31B |
| Phibro Animal Health | 2.28B |
| BioCryst Pharmaceuticals | 2.23B |
| Bausch Health Companies | 2.08B |
| ANI Pharmaceuticals | 1.81B |
| Perrigo Company | 1.58B |